HPV Vaccination Guidelines

Key Recommendations

The American College of Physicians recommends that patients with genital warts can receive HPV vaccination regardless of their current infection status, as the vaccine may still provide protection against other HPV types not yet acquired 1
The Centers for Disease Control and Prevention suggests that the presence of active genital warts does not contraindicate vaccination, and patients can still benefit from protection against other HPV types included in the vaccine 3

The quadrivalent vaccine protects against HPV types 6, 11, 16, and 18, and even if a patient is already infected with HPV types 6 or 11, they can still benefit from protection against HPV types 16 and 18, which cause 70% of cervical cancers 3, 4
Patients with genital warts can be infected simultaneously with multiple HPV types, making vaccination beneficial for protection against types not yet acquired 5

The vaccine does not treat existing genital warts or existing HPV infections, it only provides protection against future infections with vaccine-type HPV strains 3, 6
Vaccination is most effective when administered before exposure to HPV through sexual activity, but sexually active persons should still be vaccinated consistent with age-based recommendations 1

The American Academy of Pediatrics recommends HPV vaccine for females aged 9-26 years, with routine vaccination at ages 11-12 years, and for males aged 9-26 years, with routine vaccination at ages 11-12 years 1
Men who have sex with men may especially benefit from vaccination through age 26 years to prevent condyloma and anal cancer 1

The vaccine will not make existing warts resolve faster or prevent recurrence of current warts, and continued screening remains essential regardless of vaccination status 3, 4, 6
Women with genital warts do not need more frequent Pap tests than recommended, and genital warts commonly recur after treatment, especially in the first 3 months, and vaccination does not change this natural history 4